NASDAQ · CSBR
Champions Oncology, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for CSBR: Dec 21, 2026
Champions Oncology, Inc. Common Stock is estimated to report earnings on 12/21/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. The reported EPS for the same quarter last year was $0.02.
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · The Motley Fool · MarketBeat · Quiver Quantitative- Zacks · Sep 15, 11:12 AM EDTCSBR Stock Slips Post Q1 Earnings Despite Revenue, Margin GrowthChampions Oncology's first-quarter fiscal 2027 results record revenue and margin growth, stronger adjusted earnings and surging data-license revenues.
- The Motley Fool · Sep 11, 9:58 AM EDTChampions Oncology (CSBR) Q1 2027 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- MarketBeat · Sep 10, 5:02 PM EDTChampions Oncology Q1 Earnings Call HighlightsChampions Oncology (NASDAQ:CSBR) reported first-quarter fiscal 2027 revenue growth, improved margins and its fifth consecutive quarter of positive adjusted EBITDA, as both its translational oncology services and data licensing businesses contributed to results. Revenue for the q
- Zacks · Jul 30, 12:15 PM EDTCSBR Stock Dips Post Q4 Earnings Despite Record Revenue Growth, AI PushChampions Oncology reports fourth-quarter fiscal 2026 growth as revenue gains, margin improvement and operational initiatives support progress.
- MarketBeat · Jul 27, 6:02 PM EDTChampions Oncology Q4 Earnings Call HighlightsChampions Oncology (NASDAQ:CSBR) reported record revenue for fiscal 2026 and positive adjusted EBITDA in every quarter of the year, supported by growth in its core Translational Oncology Solutions, or TOS, services business and efforts to bring radiopharmaceutical work in-house.
- Zacks · Jul 23, 1:19 PM EDTCSBR vs. CTKB: Which Life Sciences Stock Has Better Long-Term Upside?Champions Oncology and Cytek Biosciences have different growth drivers and valuations, but which life sciences stock offers better long-term upside? Let's dive in.
- Zacks · Jul 23, 12:58 AM EDT2 Microcaps With Gross Margin CatalystsCSBR and CEPL have levers in place for Gross Margin improvement.
- Zacks · Jul 22, 10:13 AM EDTZacks Initiates Coverage of Champions Oncology With Neutral RecommendationDiscover why Zacks rates Champions Oncology as "Neutral", being the first on Wall Street to initiate coverage on the stock. Explore CSBR's accelerating pharmacology services and expanding data initiatives amid execution risks and commercialization timing.
- The Motley Fool · Mar 13, 9:26 AM EDTChampions Oncology (CSBR) Earnings Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- The Motley Fool · Jan 7, 10:16 AM ESTChampions Oncology (CSBR) Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- Quiver Quantitative · Jul 23, 4:56 PM EDTCHAMPIONS ONCOLOGY Earnings Results: $CSBR Reports Quarterly EarningsCHAMPIONS ONCOLOGY ($CSBR) posted quarterly earnings results on Wednesday, July 23rd. The company reported earnings of -$0.13 per share, beating estimates of -$0.20 by $0.07. The company also reported revenue of $12,360,000, beating estimates of $12,253,260 by $106,740.
- Quiver Quantitative · Jul 15, 5:09 PM EDTCHAMPIONS ONCOLOGY Earnings Preview: Recent $CSBR Insider Trading, Hedge Fund Activity, and MoreCHAMPIONS ONCOLOGY ($CSBR) is expected to release its quarterly earnings data on Thursday, July 17th after market close, per Finnhub. Analysts are expecting revenue of $12,253,260 and earnings of -$0.20 per share.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Champions Oncology, Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.